Lineage Cell Therapeutics, Inc.
$1.03
▲ +0.08
(+8.67%)
Volume: 2,480,431
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
29
- 21d momentum -8.0%
- MA aligned bearish
- RSI 47
🎯
Pullback
50
- -1.9% vs 20MA
💎
Value
58
- -51% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)47.0
MACD-0.004
MA trendBearish
ATR5.88%
21d mom.-8.0%
63d mom.-19.5%
vs 20MA-1.9%
RVOL(20)1.94×
52w low · 1
52w high · 2
-50.7% from 52-week high
20d support 1
· resistance 1
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$240M
PER—
PBR3.94
PSR18.36
EPS$-0.13
ROE-53.0%
ROA-30.4%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-7.77
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +0.00% | -8.04% | -19.53% | -32.68% | -35.63% | -37.20% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -4.63%, daily vol 3.31%. Lineage Cell Therapeutics, Inc. sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.